Anti-tumor activity of therapeutic vaccination with an autologous TriMix-dendritic cell vaccine combined with sequential interferon alfa-2b, in advanced melanoma patients (Pts) with evaluable disease

Sofie Wilgenhof; An Van Nuffel; Daphné Benteyn; L. Pierret; Carlo Heirman; Jurgen Corthals; Truus Roelandt; A. De Coninck; Ivan Van Riet; Aude Bonehill; Kris Thielemans; Bart Neyns

Anti-tumor activity of therapeutic vaccination with an autologous TriMix-dendritic cell vaccine combined with sequential interferon alfa-2b, in advanced melanoma patients (Pts) with evaluable disease

Sofie Wilgenhof, An Van Nuffel, Daphné Benteyn, L. Pierret, Carlo Heirman, Jurgen Corthals, Truus Roelandt, A. De Coninck, Ivan Van Riet, Aude Bonehill, Kris Thielemans, Bart Neyns

Research output: Chapter in Book/Report/Conference proceeding › Meeting abstract (Book)

Original language	English
Title of host publication	BSMO Annual Meeting, Brussels, Belgium
Publication status	Published - Mar 2009

Keywords

therapeutic vaccination
tri-mix
melanoma
interferon a-2b

Cite this

Wilgenhof, S., Van Nuffel, A., Benteyn, D., Pierret, L., Heirman, C., Corthals, J., Roelandt, T., De Coninck, A., Van Riet, I., Bonehill, A., Thielemans, K., & Neyns, B. (2009). Anti-tumor activity of therapeutic vaccination with an autologous TriMix-dendritic cell vaccine combined with sequential interferon alfa-2b, in advanced melanoma patients (Pts) with evaluable disease. In BSMO Annual Meeting, Brussels, Belgium

@inbook{b0eeb132eeee42e8bce9c3dfc2b8d239,

title = "Anti-tumor activity of therapeutic vaccination with an autologous TriMix-dendritic cell vaccine combined with sequential interferon alfa-2b, in advanced melanoma patients (Pts) with evaluable disease",

keywords = "therapeutic vaccination, tri-mix, melanoma, interferon a-2b",

author = "Sofie Wilgenhof and {Van Nuffel}, An and Daphn{\'e} Benteyn and L. Pierret and Carlo Heirman and Jurgen Corthals and Truus Roelandt and {De Coninck}, A. and {Van Riet}, Ivan and Aude Bonehill and Kris Thielemans and Bart Neyns",

year = "2009",

month = mar,

language = "English",

booktitle = "BSMO Annual Meeting, Brussels, Belgium",

}

Wilgenhof, S, Van Nuffel, A, Benteyn, D, Pierret, L, Heirman, C, Corthals, J, Roelandt, T, De Coninck, A, Van Riet, I, Bonehill, A, Thielemans, K & Neyns, B 2009, Anti-tumor activity of therapeutic vaccination with an autologous TriMix-dendritic cell vaccine combined with sequential interferon alfa-2b, in advanced melanoma patients (Pts) with evaluable disease. in BSMO Annual Meeting, Brussels, Belgium.

Anti-tumor activity of therapeutic vaccination with an autologous TriMix-dendritic cell vaccine combined with sequential interferon alfa-2b, in advanced melanoma patients (Pts) with evaluable disease. / Wilgenhof, Sofie; Van Nuffel, An; Benteyn, Daphné et al.
BSMO Annual Meeting, Brussels, Belgium. 2009.

Research output: Chapter in Book/Report/Conference proceeding › Meeting abstract (Book)

TY - CHAP

T1 - Anti-tumor activity of therapeutic vaccination with an autologous TriMix-dendritic cell vaccine combined with sequential interferon alfa-2b, in advanced melanoma patients (Pts) with evaluable disease

AU - Wilgenhof, Sofie

AU - Van Nuffel, An

AU - Benteyn, Daphné

AU - Pierret, L.

AU - Heirman, Carlo

AU - Corthals, Jurgen

AU - Roelandt, Truus

AU - De Coninck, A.

AU - Van Riet, Ivan

AU - Bonehill, Aude

AU - Thielemans, Kris

AU - Neyns, Bart

PY - 2009/3

Y1 - 2009/3

KW - therapeutic vaccination

KW - tri-mix

KW - melanoma

KW - interferon a-2b

M3 - Meeting abstract (Book)

BT - BSMO Annual Meeting, Brussels, Belgium

ER -